Correlation Between Acumen Pharmaceuticals and Acer Therapeutics
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Acer Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Acer Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Acer Therapeutics, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Acer Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Acer Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Acer Therapeutics.
Diversification Opportunities for Acumen Pharmaceuticals and Acer Therapeutics
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Acumen and Acer is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Acer Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acer Therapeutics and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Acer Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acer Therapeutics has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Acer Therapeutics go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Acer Therapeutics
If you would invest 81.00 in Acer Therapeutics on January 25, 2024 and sell it today you would earn a total of 0.00 from holding Acer Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 4.55% |
Values | Daily Returns |
Acumen Pharmaceuticals vs. Acer Therapeutics
Performance |
Timeline |
Acumen Pharmaceuticals |
Acer Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Acumen Pharmaceuticals and Acer Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acumen Pharmaceuticals and Acer Therapeutics
The main advantage of trading using opposite Acumen Pharmaceuticals and Acer Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Acer Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acer Therapeutics will offset losses from the drop in Acer Therapeutics' long position.Acumen Pharmaceuticals vs. Terns Pharmaceuticals | Acumen Pharmaceuticals vs. X4 Pharmaceuticals | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Hookipa Pharma |
Acer Therapeutics vs. NRx Pharmaceuticals | Acer Therapeutics vs. Pasithea Therapeutics Corp | Acer Therapeutics vs. SAB Biotherapeutics | Acer Therapeutics vs. Lexaria Bioscience Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Money Managers Screen money managers from public funds and ETFs managed around the world |